Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
3,592
-4,090
-53% -$373K 0.19% 109
2026
Q1
$789K Sell
7,682
-14
-0.2% -$1.58K 0.54% 63
2025
Q4
$964K Buy
7,696
+570
+8% +$72.6K 0.66% 50
2025
Q3
$954K Sell
7,126
-58
-0.8% -$7.61K 0.69% 53
2025
Q2
$977K Buy
7,184
+160
+2% +$21.1K 0.76% 48
2025
Q1
$932K Buy
7,024
+125
+2% +$15.9K 0.84% 46
2024
Q4
$780K Buy
6,899
+339
+5% +$39.2K 0.67% 50
2024
Q3
$748K Buy
+6,560
New +$720K 0.65% 59

Other funds holding ABT

Paladin Wealth's ABT Position: Q2 2026 in Review

Paladin Wealth reduced its Abbott (ABT) stake by 53% in Q2 2026, selling an estimated $373K and leaving 3,592 shares worth $326K. The position accounts for 0.19% of the portfolio, ranked #109.

Paladin Wealth first reported a position in ABT in Q3 2024 and has held it in 8 quarters since. The position peaked at $977K in Q2 2025. 530 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Paladin Wealth held 3,592 shares of Abbott worth $326K as of Q2 2026.
  • Paladin Wealth sold 4,090 Abbott shares in Q2 2026, an estimated $373K.
  • Abbott made up 0.19% of Paladin Wealth's portfolio in Q2 2026, its #109 holding.
  • Paladin Wealth first reported a position in Abbott in Q3 2024 and has held it in 8 quarters since.
  • Paladin Wealth's Abbott position peaked at $977K in Q2 2025.
  • 530 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.